- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.05. | Cannara Biotech Inc (2): Cannara Biotech closes Medican Organic acquisition | 1 | Stockwatch | ||
| 14.04. | Cannara Biotech GAAP EPS of $0.02, revenue of $27.1M | 1 | Seeking Alpha | ||
| 14.04. | Cannara Biotech Inc.: Cannara Reports Q2 Fiscal 2026 Results with Continued Profitability, Strong Operating Cash Flow and #1 Retail Market Share in Québec | 292 | GlobeNewswire (Europe) | Delivered strong Q2 financial results: Generated $27.2 million in total net revenues, $11.6 million in gross profit before fair value adjustments or 43% of revenues, $6.0 million in adjusted EBITDA1... ► Artikel lesen | |
| 08.04. | Cannara Biotech is a buy, this analyst says | 1 | Cantech Letter | ||
| CANNARA BIOTECH Aktie jetzt für 0€ handeln | |||||
| 07.04. | Cannara Biotech Inc (2): Cannara Biotech to release fiscal Q2 results April 14 | 1 | Stockwatch | ||
| 07.04. | Stocks in Play: Cannara Biotech Inc. | 1 | Baystreet.ca | ||
| 19.03. | CEO Clips: Video - CEO Clips: Cannara Biotech Graduates to Toronto Stock Exchange | 332 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - March 19, 2026) - Cannara Biotech Inc. (TSX: LOVE) (OTCQX: LOVFF) (FSE: 8CB0) is a vertically integrated producer of affordable premium-grade cannabis... ► Artikel lesen | |
| 17.03. | Toronto Stock Exchange: Cannara Biotech Inc. (LOVE) Opens the Market | 426 | Newsfile | Toronto, Ontario--(Newsfile Corp. - March 17, 2026) - Donald Olds, Lead Director and Chairman of the Audit and Governance Committee, Cannara Biotech Inc. ("Cannara" or the "Company") (TSX: LOVE)... ► Artikel lesen | |
| 27.02. | Cannara Biotech Inc (2): Cannara receives final OK to transfer shares to TSX | 1 | Stockwatch | ||
| 27.02. | Cannara Biotech Inc (2): Cannara Biotech to delist from TSX-V | 2 | Stockwatch | ||
| 26.02. | Cannara Biotech Inc.: Cannara Announces Graduation to the Toronto Stock Exchange | 254 | GlobeNewswire (Europe) | MONTREAL, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV: LOVE) (OTCQX: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis... ► Artikel lesen | |
| 19.02. | Cannara Biotech Inc (2): Cannara Biotech three-million-share private placement | 4 | Stockwatch | ||
| 13.02. | Cannara Biotech Inc (2): Cannara Biotech to host investor webcast Feb. 19 | 1 | Stockwatch | ||
| 12.02. | Cannara Biotech Inc.: Cannara to Host Investor Webcast on February 19th, 2026 | 1 | GlobeNewswire (USA) | ||
| 04.02. | Cannara Biotech Inc (2): Cannara Biotech closes $6.3-million private placement | 2 | Stockwatch | ||
| 02.02. | Cannara Biotech Q1 2026 slides: Record margins and Quebec market leadership | 3 | Investing.com | ||
| 02.02. | Cannara Biotech überzeugt mit Rekordmargen und Marktführerschaft in Quebec | 2 | Investing.com Deutsch | ||
| 28.01. | Cannara Biotech Inc (2): Cannara receives conditional OK for TSX uplisting | 1 | Stockwatch | ||
| 26.01. | Cannara Biotech: Starkes Wachstum und Marktführerschaft im ersten Quartal 2026 | 2 | Investing.com Deutsch | ||
| 26.01. | Cannara Biotech Inc.: Cannara Reports Q1 Fiscal 2026 Results, Delivers New Record Financial Results, Extends Market Share Gains and Advances Disciplined Expansion Strategy | 354 | GlobeNewswire (Europe) | New Record Financial Results: Total revenues of $30.1 million, gross profit before fair value adjustments of $13.5 million or 45% and Adjusted EBITDA of $8.8 million1, supported by operating cash... ► Artikel lesen |
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 37,700 | -1,18 % | Vorsicht bei BioNTech! Novo Nordisk gibt Gas! Kaufchance bei Vidac Pharma Aktie! | Kaufstimmung bei Novo Nordisk. Die Aktie des dänischen Pharmagiganten scheint den seit Sommer 2024 begonnenen Abwärtstrend zu verlassen. Anleger reagieren auf positive Meldungen. Bei Vidac Pharma ist... ► Artikel lesen | |
| AURORA CANNABIS | 3,144 | +0,58 % | War das erst der Anfang? Warum der Aurora-Deal und ein 50-Millionen-AUD-Vertrag Bioxyne weiteren Schub geben könnten | ||
| CANOPY GROWTH | 0,935 | +0,45 % | Canopy Growth Corporation: Canopy Growth Relaunches Tweed Brand in Germany with New MTL Cannabis Strain Lineup, Marking First International Release following Acquisition | Pablo's Revenge, Dante'z Inferno, and Frost'd Flakes launched under Tweed brand Up to five additional strains expected to follow in June 2026 Company targeting rapid growth in Germany's medical... ► Artikel lesen | |
| STADA ARZNEIMITTEL | - | - | Enzymatica AB: Quarterly report Q1/2026 - Enzymatica strengthens international position through STADA agreement | First quarter
Net sales amounted to SEK 11.4 million (12.3).
Operating result amounted to SEK -13.6.million (-18.0)
Earnings per share, before... ► Artikel lesen | |
| TILRAY BRANDS | 4,730 | +0,11 % | Tilray Brands, Inc.: BrewDog verwandelt die diesjährige Fußball-WM in ein landesweites Sommerfest rund um Bier, Bars und große Spielmoment | BrewDog startet die Multichannel-Kampagne "Underdog" im Einzelhandel, in Bars und in digitalen Medien - einschließlich des landesweiten Gewinnspiels "Win a Year of Beer" und öffentlicher Public-Viewing-Events... ► Artikel lesen | |
| INNOCAN PHARMA | 2,240 | +2,75 % | Innocan Pharma Corporation: Innocan Pharma Posts Strong Q1 2026 Results*, With Revenue Surging 29.7% to US$6.47M | HERZLIYA, Israel and CALGARY, AB, May 27, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company... ► Artikel lesen | |
| CRONOS GROUP | 2,414 | -0,98 % | Cronos Group Inc.: Cronos Group Reports 2026 First Quarter Results | Net revenue in Q1 2026 increased by 40% year-over-year to $45.2 million Achieved record net revenue and gross profit in Q1 2026 Reached #1 market share in vapes in Canada1 Ninth consecutive quarter... ► Artikel lesen | |
| SYNBIOTIC | 1,696 | -1,17 % | EQS-News: SYNBIOTIC SE: SYNBIOTIC startet mit operativem Fortschritt, neuen regulatorischen Impulsen und starker Branchenpräsenz ins Frühjahr 2026 | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Marktbericht/Prognose
SYNBIOTIC startet mit operativem Fortschritt, neuen regulatorischen Impulsen und starker Branchenpräsenz ins Frühjahr... ► Artikel lesen | |
| DIGICANN VENTURES | 0,001 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Announces Resignation of Director | Vancouver, British Columbia--(Newsfile Corp. - April 8, 2026) - Digicann Ventures Ltd. (CSE: DCNN.X) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the cannabis... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 0,944 | -3,28 % | Organigram Global Inc.: Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities | Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram") and Sanity Group GmbH ("Sanity" or "Sanity Group") jointly announced the successful closing of Organigram's previously... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 7,070 | 0,00 % | Green Thumb Industries: Marijuana Meme Stock or Dream Stock? | ||
| SNDL | 1,238 | -1,04 % | 1CM Inc.: 1CM Provides Update on Arrangement Agreement with SNDL | Toronto, Ontario--(Newsfile Corp. - May 27, 2026) - 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM") announces that it does not expect the proposed sale of its Ontario retail locations to... ► Artikel lesen | |
| CRESCO LABS | 0,769 | -5,53 % | Cresco Labs Inc: Cresco Labs registers medical pot operations with DEA | ||
| NOVERIS HEALTH SCIENCES | 1,440 | +11,63 % | XFRA 0NF1: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| WAYLAND GROUP | - | - | EQS-News: Berger Montague (Canada) PC: Ankündigung der Anhörung zur Genehmigung des Vergleichs - Wayland Group Corp., Scott Langille, Gerhard Müller, Paul Pathak, Eric Silver, M. Stein, John Does 1-3, Canaccord Genuity Corp. und RF Securities Clearing LP | EQS-News: Berger Montague (Canada) PC
/ Schlagwort(e): Rechtssache/Sonstiges
ANKÜNDIGUNG DER ANHÖRUNG ZUR GENEHMIGUNG DES VERGLEICHS - KURZFASSUNG - WAYLAND... ► Artikel lesen |
Das Unternehmen CANNARA BIOTECH INC kann der Branche Pharma zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,015 (-1,49 %) liegt der Kurs bei 0,995 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CANNARA BIOTECH INC finden Sie auf Wallstreet Online.